Alphatec Holdings, Inc.
HealthcareNASDAQ:ATEC · NASDAQ Global Select
+$0.15 today
Vol 1.74M · Avg 3.20M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-397.9%
avg -160.7%
ROIC
-12.8%
avg -37.8%
ROA
-18.1%
avg -32.5%
Analysis
ROIC is currently the strongest return metric at -12.8% versus its period average of -37.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Craig E. Hunsaker | Executive Vice President of People and Culture | $1.80M | — | 62 | $1.73M | 1.12% |
Patrick S. Miles | Chairman, CEO & President | $1.40M | — | 60 | $600,381.00 | 0.39% |
David Sponsel | Executive Vice President of Sales | $929,745.00 | — | 47 | $0.00 | <0.01% |
Scott Lish | Chief Operating Officer | $777,091.00 | — | 45 | $815,704.00 | 0.53% |
J. Todd Koning | Executive Vice President & Chief Financial Officer | $767,431.00 | — | 53 | $600,721.00 | 0.39% |
Luiz Pimenta | Chief Medical Officer | — | — | — | — | — |
Ali Shorooghi | Senior Vice President of Marketing | — | — | 40 | — | — |
Jonathan Allen | Executive Vice President of Commercial Operations | — | — | 66 | $134,728.00 | 0.09% |
Robert Judd | Vice President of Finance and Investor Relations & Controller | — | — | — | — | — |
Tyson Eliot Marshall | General Counsel & Corporate Secretary | — | — | 52 | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
3
$996,192.35
Sells
60
$107.77M
Net Sentiment
$106.78M
Net selling
Most Active
Lish Scott
11 transactions
1–10 of 63
Analysis
Insiders reported 3 buys worth $996,192.35 and 60 sells worth $107.77M over the last 12 months. That adds up to net selling of $106.78M. Lish Scott was the most active insider with 11 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | -1.9% | +14.9% (15yr)7 analysts |
| Net Income | N/A | N/A | N/A | N/A7 analysts |
| EBIT | N/A | N/A | N/A | N/A7 analysts |
Analysis
Recent growth has been strongest in Revenue at -1.9% over three years. Forward estimates point to Revenue at +14.9% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Legend Biotech Corporation
NASDAQ:LEGN
$6.63B
Cidara Therapeutics, Inc.
CDTX
$5.61B
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.29B
LivaNova PLC
NASDAQ:LIVN
$4.36B
Heartflow, Inc. Common Stock
NASDAQ:HTFL
$2.87B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.82B
Disc Medicine, Inc.
NASDAQ:IRON
$2.60B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.55B
Surgery Partners, Inc.
NASDAQ:SGRY
$2.00B
Zai Lab Limited
NASDAQ:ZLAB
$1.92B
Who manages ATEC?
Alphatec Holdings, Inc. (ATEC) lists 10 active executives. The top listed executive is Luiz Pimenta, Chief Medical Officer.
Are ATEC insiders buying or selling?
Recent insider activity shows net selling of $126.52M.
Explore More
Continue the stock analysis
Jump to another research area for this company.